Skip to main content
2026 CRT Conference Main banner

CRT 2026

Late-Breaking Clinical Trials

Session:: Late-Breaking Clinical Trials | Coronary III

Effect of Low-Dose Dobutamine Infusion on N-terminal Pro B-type Natriuretic Peptide in Risk Patients With Acute Myocardial Infarction (DOBERMANN-D) - A Randomized Clinical Trial

Sunday, March 8, 2026
4:19 PM - 4:27 PM EST
Location: International Ballroom Center

    Speaker(s)

  • Sarah Louise Duus Holle, MD

    Ph.D. student at the Heart Centre
    Rigshospitalet, Copenhagen University Hospital

    Disclosure(s): Novo Nordisk: Employee (Ongoing); Novo Nordisk Foundation: Grant/Research Support (Ongoing)